Viridian Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2018 - 2014
Period Ending	Feb '25 Feb 20, 2025	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2018 - 2014
Market Capitalization	1,019	899	976	317	47	12	Upgrade
Market Cap Growth	136.09%	-7.85%	207.65%	573.54%	308.81%	-84.29%	Upgrade
Enterprise Value	591	777	741	280	32	-7	Upgrade
Last Close Price	13.28	16.90	24.32	16.17	20.30	38.05	Upgrade
PS Ratio	5752.02	3647.53	663.46	144.94	61.23	3.42	Upgrade
PB Ratio	2.46	2.59	2.98	2.29	0.54	0.97	Upgrade
P/TBV Ratio	3.35	4.86	4.65	7.97	-	0.97	Upgrade
EV/Sales Ratio	4596.22	3150.76	503.65	127.79	41.48	-	Upgrade
Debt / Equity Ratio	0.03	0.05	0.01	0.00	0.00	0.53	Upgrade
Asset Turnover	0.00	0.00	0.01	0.02	0.01	0.09	Upgrade
Quick Ratio	18.21	17.93	12.73	14.48	11.96	2.67	Upgrade
Current Ratio	18.55	18.26	12.93	14.68	12.14	2.92	Upgrade
Return on Equity (ROE)	-51.88%	-56.80%	-44.57%	-51.61%	-163.07%	-124.81%	Upgrade
Return on Assets (ROA)	-32.14%	-34.37%	-26.28%	-29.75%	-31.36%	-51.84%	Upgrade
Return on Capital (ROIC)	-34.14%	-36.80%	-28.52%	-32.28%	-35.04%	-58.31%	Upgrade
Earnings Yield	-18.81%	-20.76%	-11.05%	-18.49%	-172.21%	-274.49%	Upgrade
FCF Yield	-14.45%	-16.16%	-8.05%	-12.79%	-46.39%	-236.90%	Upgrade
Buyback Yield / Dilution	-42.07%	-39.48%	-169.22%	-235.07%	-70.27%	-5.87%	Upgrade
Total Shareholder Return	-42.07%	-39.48%	-169.22%	-235.07%	-70.27%	-5.87%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.